Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya.

ABSTRACT:

Background

In Kenya, access to early infant diagnosis and viral load monitoring services for HIV patients on ART is significantly hampered by sample transportation challenges and long turnaround times. Near patient care testing technologies have the potential to obviate such constraints. The Cepheid GeneXpert was launched in 2010 as a TB assay and in 2014 as a potential point of care HIV viral load assay. Whereas it is widely is used for TB in Kenya, its utility for HIV testing has not been evaluated.

Objective

To investigate the performance and usability characteristics of the GeneXpert HIV-1 qualitative and quantitative assay.

Methods

This was a cross sectional study among 911 HIV Exposed infants and 310 HIV positive adults. Existing machines used for routine TB dia

SUBMITTER: Bwana P 

PROVIDER: S-EPMC6430374 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature